HVAX Horizons Global Vaccines and Infectious Diseases Index ETF

TORONTO, May 26, 2023 /CNW/ - Horizons ETFs Management (Canada) Inc. (the "Manager") announced today that it will be terminating three of its exchange traded funds (the "ETFs") effective at the close of business on or about August 8, 2023 (the "Termination Date"). Details of the terminating ETFs are as follows:

Effective immediately, except in limited circumstances, no further direct subscriptions for units of the ETFs will be accepted. The ETFs are expected to be de-listed from the Toronto Stock Exchange, at the request of the Manager, at the close of business on or about August 1, 2023, with all units still held by investors being subject to a mandatory redemption as of the Termination Date.

Any remaining unitholders of an ETF as at the Termination Date will receive the net proceeds from the liquidation of the assets, less all liabilities and all expenses incurred in connection with the dissolution of the ETF, on a pro rata basis.

Horizons ETFs Management (Canada) Inc. is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada. The Horizons ETFs product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs has over $25 billion of assets under management and 107 exchange traded funds listed on major Canadian stock exchanges.

Commissions, management fees and expenses all may be associated with an investment in exchange traded products (the "Horizons Exchange Traded Products") managed by Horizons ETFs Management (Canada) Inc. The Horizons Exchange Traded Products are not guaranteed, their values change frequently and past performance may not be repeated. The prospectus contains important detailed information about the Horizons Exchange Traded Products. Please read the relevant prospectus before investing.

SOURCE Horizons ETFs Management (Canada) Inc.